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1Abstract:
Since their discovery over a century ago, antibiotics have been a staple of
combating infectious diseases. However, bacteria develop resistance to antibiotics
through a variety of mechanisms. Efforts to identify new antibiotics often fail by
discovering already-known antibiotics, or failing to synthesize new antibiotics that
are safe for clinical use. The aim of this research was to dereplicate bacteria- to
screen for antibiotic production in- normally isolated in cave ecosystems. Using two
new technologies, the Antibiotic Resistance Platform (ARP) and a data acquisition
and bioinformatics technique (IDBac), my dereplicating method allowed high
throughput of bacterial screening for antibiotics. In this work, 252 bacterial isolates
from Lechuguilla Cave, NM, were screened using IDBac spectra data to cluster into
21 unique groups. These groups were then dereplicated for novel antibiotic
production using the ARP using an Escherichia coli ΔΔbamBtolC mutant with
limited efflux that was previously engineered to express resistance genes to several
classes of antibiotics. Growth of the E.coli resistant strains indicated which
antibiotics were being produced, while those with no growth had the potential to
produce an unknown antibiotic or adjuvant. Using this approach, a library of over
600 bacterial strains was dereplicated and 18 lead strains were identified. This novel
dereplication method therefore demonstrates the ability to rapidly screen cave
isolates, allowing large libraries of isolates to be rapidly screened in the future for
novel antibiotics.
2Introduction:
Antimicrobial resistance (AMR) is one of the most significant challenges facing
human health. In 2019, the CDC [1] estimated that 2.8 million infections, 35,000
deaths, and billions of dollars in treatment costs are the result of AMR. Future
projections paint a bleak picture of the AMR crisis, including a projection of a $100.2
trillion loss in global GDP and 10 million annual deaths due to AMR by 2050 [20].
Newly discovered mechanisms of antibiotic resistance and an increased clinical
prevalence of antibiotic-resistant bacterial infections is also a direct result of AMR [1,
8]. Key efforts to combat AMR include: detection and prevention of resistant-
bacterial infections, responding rapidly to unusual genes (i.e mutations in DNA
resulting in AMR) and microorganisms, investment in novel antibiotic discovery,
preventing the dissemination of resistance genes, and reducing the unnecessary use of
antibiotics (ABs) [1, 3].
Most antibiotics are produced by other microorganisms; however, it is
difficult to isolate and discover novel bacterial species and antibiotics. For example,
common soil bacteria can harbor a variety of natural products (NPs) that are abundant
sources of antibiotics. But soil is commonly mined for NPs and no longer yields
promising results with regards to fighting AMR [4]. However, bacteria found in
highly isolated and unexplored environments, such as cave and deep-sea ecosystems,
may harbor an unexplored chemical diversity [6,13]. This novel chemical diversity
could lead to discovery of new NPs, supported by findings of complex resistomes, a
collection of complex antibiotic resistance genes, in these environments [7,10]. These
resistomes imply the existence of extensive antibiotic production in these isolated
environments, and investigating them may be a promising venture in alleviating the
AMR crisis.
Lechuguilla Cave, NM is an isolated environment. Lechuguilla’s formation was
not driven by surface, meteoric water, as with most other cave systems, but with
oxidation of ascending hydrogen sulfide from a nearby basin to make sulfuric acid
[20]. The cave system was also discovered in 1986 and has had limited human access,
controlled by the National Park Service [19]. Despite this isolation, Lechuguilla Cave
is home to numerous microbes that are resistant to several commonly used antibiotics
[19], and it has been suggested that this resistance is due to high levels of antibiotic
production, as bacteria compete for the limited nutrients within the cave. Such
responses are explained by the Red Queen Hypothesis which proposes that species
must adapt in order to maintain their competitive advantage for resources.
3To screen the bacteria from the cave for antibiotics, two such techniques
will be used in combination: IDBac a data acquisition and bioinformatics
technique and the Antibiotic Resistance Platform (ARP) which identifies bacteria
and removes them from consideration based on the production of already-known
antibiotics [2, 3]. IDBac utilizes MALDI-TOF mass spectroscopy to distinguish
and group bacterial strains based on the natural products they produce [2].
Grouping strains directly based on metabolites allows you to pick a few “lead”
strains that may be producing novel NPs, leading to higher throughput in novel
antibiotic discovery. While IDBac allows you to narrow down a library of isolates
to those that are novel (a process called dereplication), The Antibiotic Resistance
Platform (ARP) can then be used to screen strains for novel antibiotics. The ARP
consists of a map of known antibiotic resistance genes that increases throughput
by identifying if a bacterial strain is producing an already-known antibiotic,
preventing antibiotic rediscovery [3]. Here, I screened the Lechuguilla cave
culture library for novel antibiotics using IDBac and the ARP to form a single,
high throughput workflow (Figure 1). By combining these techniques I have
demonstrated a high throughput method that allowed me to screen ~300 bacterial
strains to find 18 novel strains to examine for antibiotic production.
Figure 1. Depiction of high throughput dereplication using IDBac and the ARP. This general overview
portrays how a large bacterial library can be dereplicated to fewer lead strains possibly producing novel
antibiotics.
4Methods:
Library Building
The Lechuguilla culture library contained over 600 strains collected from
Lechuguilla Cave, Eddy County, NM. This library was generated from bacterial
isolates collected in 2005 under a permit for sample collection [19]. Sample were
collected from five sites in the cave. Sites were chosen based on factors such as
mineral composition and isolation from human activity: LCDS1, LCGW, LCEAE,
LCEA1, and LCBP. All strains that were successfully cultured were preserved at -
80°C in 25% wt/wt glycerol- 50% Tripticase soy broth (TSB) [Casein 17g/L,
Papaic digest of Soybean 3g/L, Dextrose 2.5g/L, Sodium Chloride 5g/L,
potassium Phosphate 2.5g/L].
Figure 2. Map of Lechuguilla Cave highlighting sample collection sites. Red triangles mark where LC
strains were collected. Blue triangles mark where KB strains were collected. Note that both LC and KB
strains were collected at the LCECE site.
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All strains in this work were grown from freezer stocks on 50% TSA for 7
days prior to spotting onto a MALDI plate in triplicate using sterile toothpicks.
1μL 70% formic acid was then applied to each spot and allowed to air dry,
followed by 1μL 10 mg/mL MALDI-grade matrix [50% acetonitrile (ACN),
47.5% water (H2O), 2.5% trifluoroacetic acid (TFA), and 10 mg recrystallized α-
cyano-4-hydroxycinnamic acid (CHCA)]. After adding matrix, the plate was air
dried for five minutes. The MALDI mass spectroscopy was then performed using
an Autoflex Speed LRF mass spectrometer (Bruker Daltonics, Billerica, MA)
equipped with a smartbeam-II laser (355 nm) [4].
IDBac Data Analysis
MALDI spectra were analyzed using IDBac v1.1.10 [4]. Protein spectra
(>2000 Da) were used to build a dendrogram analogous to a phylogenetic tree.
Parameters were set at percent presence at 66% (signal to noise ration at 4, lower
mass cutoff at 200, upper mass cutoff at 2000) and ppm tolerance at 3000. This
dendrogram was exported and viewed using FigTree 1.4.4 [17], then manually
annotated. Dendrogram groupings were verified using mirror plots (Figure 3). To
compare small molecule (<2000Da) production within groups, molecule analysis
networks (MAN) were generated using IDBac. MANs were used to determine
lead strains for the next stage of the workflow, based on the degree of similarity
of metabolite profiles to other members of that group (Figure 5).
Figure 3. Two example mirror plots and a picture of a MALDI-TOF plate (A) used in the dereplication
process. (B) Mirror plot of strains KB068 and KB080. (C) Mirror plot of KB068 and LC529. Note that B
displays more matches in intensity peaks than in C, indicating a close relationship between KB068 and
KB080 compared to KB068 and LC529.
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ARP template creation
An ARP template was created for strain dereplication after IDBac analysis
which uses a bamBtolC (membrane assembly) and tolC (antibiotic export) gene
knock-out in Escherichia coli (ΔΔ bamBtolC) expressing an array of antibiotic
resistance cassettes (Figure 4) was used as described in [5].
The lead strains selected for antibiotic dereplication were grown on 1/2 TSA for
seven days. Thereafter, strains were inoculated into 3mL of Streptomyces antibiotic
activity media [SAM; 15g/L glucose, 15g/L soytone, 5g/L NaCl, 1g/L yeast extract,
1g/L CaCO3, 2.5 mL/L glycerol, and pH to 6.8±.05] and incubated at 30°C for seven
days shaking at 100 rpm. Following incubation, 200μL of the SAM culture was
inoculated onto an Omni Tray (Thermo Scientific) containing 20mL Bennet’s agar
[10g/L potato starch, 2g/L casamino acids, 1.8g/L yeast extract, 2mL/L Czapek
mineral mix, 15g/L agar, and pH to 6.8±.05]. A sheet of sterile Nitrocellulose
membrane (Merck Millipore Ltd., MA) used to induce fermentation was placed on
the agar and plates were incubated for six days at 30°C. The membrane was removed
and a 20mL Mueller Hinton agar (MHA) (BD Difco, MD) overlay was then poured
onto the surface of the plate and allowed to solidify overnight.
Antibiotic Class Antibiotic Resistance Gene(s)
Β-lactams
Penicillin
NDM-1, CTX-15-M, VIM-
2. IMP-7, KPC-2, TEM-1Cephalosporin
Carbapenam
Oxacillin OXA-10, OXA-48
Lincosamides Lincosamides ermC
Macrolides Macrolides ermC
Type B
Streptogramins Type B Streptogramins ermC
Fosfomycins Fosfomycins fosA
Rifamycins Rifamycins arr
Figure 4. ARP template (A) and a table showing antibiotic and antibiotic class represented by resistance
genes in the map (B). Each box in the map corresponds to a well on a 96 well plate containing an E. coli
strain with the denoted resistance gene or lack thereof in ΔΔ strains. Boxes in pink represent controls.
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A 96-well plate with each well containing 100μL of Mueller Hinton Broth (MHB)
with the ARP E.coli strains was plated on top using a 3μL pinning tool and incubated
at 37°C overnight, and then inspected for growth. If the E.coli strain grows, this
indicates that the antibiotic it is resistant to is being made (Figure 4).
Results:
The Lechuguilla strain library contains over 600 different bacterial isolates. Of
those, 252 were chosen for IDBac in addition to several strains that demonstrated
crystal production, indicative of small metabolite production. Using IDBac, we
determined that there were 21 distinct groups among the library based on small
metabolite and protein spectra displayed in small molecule networks (Figure 5).
Groups were determined after a dendrogram was created displaying relatedness of
isolates based on IDBac data [17]. After each group was analyzed, 116 strains were
determined to be eligible for ARP dereplication based on amount of unique metabolite
production and amount of metabolites made in common with other strains in the group
(Figure 5B). To be chosen for ARP dereplication, an isolate needed to be producing at
least 5 unique NPs in its group. The MAN further narrowed isolates within groups via
color-coded nodes representing NPs. If 2 or more isolates shared production of many
NPs, the isolate with more unique NPs being produced was chosen for ARP
dereplication.
While 116 isolates were dereplicated, only 22 isolates had readable results.
This was due to an overabundance of test culture growth on the agar overlay which
was indistinguishable from the E.coli growth. Using the ARP template, four strains
showed “negative” results via failure to prevent the growth of any E.coli on the
overlay, indicating no antibiotic production (Figure 6). On the other hand, 17 strains
gave positive results.
Figure 5. Results of IDBac. (A) Dendrogram produced by IDBac analysis paired with FigTree 1.4.4 [17]. (B)
Group 3’s small molecule analysis network (MAN) with small dots representing metabolites being produced by
isolates represented by larger dots and the lines connecting them. Strains with the most unique metabolites in a
group, such as LC415 in group 3, were chosen for ARP dereplication. A table of every group and it’s strain are
found in the Appendix.
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IDBac Group Likely group-Genera identified using 16s
RNA sequencing on isolates within groups
1 Streptomyces
2 Likely Janibacter
3 Likely Rhodococcus
4 Unknown
5 Unknown
6 Microbacterium
7 Unknown
8 Brevibacterium
9 Knoellia
10 Likely Nocardia
11 Microbacterium
12 Dietzia
13 Unknown
14 Streptomyces
15 Likely Microbacterium
16 Unknown
17 Unknown
18 Likely Microbacterium
19 Likely Nocardia
20 Unknown
21 Likely Streptomyces
Figure 6. ARP results with examples of a negative and positive result. LC30 (B) is a negative since all E.
coli colonies grew being resistant to any antibiotic LC30 may be producing. Meanwhile LC492 (B) may
be producing an antibiotic adjuvant. Because only E. coli colonies with a KPC-2 resistance gene grew,
LC492 may be producing a β-lactam class antibiotic.
Table 1.
IDBac groups (Figure 5) and the genera of most if not all isolates within each group identified
using 16s RNA sequencing.
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Most positive-result- plates showed similar growth patterns of the remaining E. coli
strains, specifically wild-type (wt) and strains containing the KPC-2 resistance gene.
In all, eight strains prevented growth of E. coli on the overlay except in wt and KPC-
2 colonies. In addition, six strains prevented growth of E. coli containing NDM-1,
four strains for VIM-2 genes, and three strains for mphA-containing colonies. One
strain, LC277 inhibited E. coli growth except in fosA-containing colonies, indicating
fosfomycin production (Figure 7). Two strains in particular, KB017A and LC350,
showed the most interesting results with no E. coli growth. This may be due to
them producing an unknown antibiotic compound. LC450 and LC418 displayed
similar results with no growth of most E. coli except for a single wt colony
and two wt colonies to grow respectively. All readable results for respective strains
can be found in Table 2.
Group Strain Dereplication Result Resistance gene
2 KB050 Positive KPC-2
3
LC099 Negative
LC277 Positive fosA
LC125 Positive mphA
LC492 Positive KPC-2
Figure 7. LC277 dereplication results and possible NP identification using IDBac spectra data. (A) The
dereplication results of LC277 as shown by E. coli growth on the agar overlay. (B) Spectra of small
metabolites LC277 produces as determined by IDBac. Note that there is a peak at ~138 m/z,
corresponding to a peak produced by fosfomycin (C) when ionized, indicating its presence.
Table 2.
A list of strains and their ARP results. If the result is positive, the resistance gene
listed alongside it is found in the E. coli colonies that grew and indicates what class of
antibiotic is being produced by the Lechuguilla strain (reference figure 4). If the result
is positive (adjuvant), then the Resistance gene listed alongside it is found only in the
E. coli colonies that did not grow and indicates an adjuvant that prevented growth of
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Discussion:
By combining IDBac and the ARP, I hoped to demonstrate a high throughput
workflow for discovery novel antibiotics from the Lechuguilla Cave culture
collection, allowing for rapid screening of NPs. While the main goal of this research
was to develop a high throughput screening process, this method revealed the
possibility for the existence of novel antiobiotic production in 4 bacterial isolates:
KB017A, LC350 (Microbacterium oxydans), LC418, and LC450 (Kocuria rosea).
These isolates are considered “lead strains” (Figure 1) and should be screened
further to reveal if they indeed produce a novel antibiotic. Importantly, only 252 of
the 600 isolates currently collected were screened and the remaining isolates should
be screened as well, including those that are the same genera as LC350 and LC450.
Then, isolates with unknown identities should be screened including those
identified in the future. If more isolates are collected from more sites throughout the
cave, the number of lead trains may grow as separate sites may select for different
antibiotic production.
Finding novel antibiotics in a relatively short time-span is critical in the fight
against AMR and its ramifications. In this work, I demonstrated that combining
IDBac and the ARP was a high throughput method that lead to the rapid screening of
252 isolates to produce 4 lead strains. While 16s RNA is essential in bacterial
identification, IDBac was able to cluster 252 strains into 21 groups that had closely
related isolates. Using this two-step dereplication, especially to dereplicate
oligotrophic bacteria, researchers can find novel antiobiotic compunds quickly and
affordably. Therefore, this novel dereplication method can allows us to better contend
with AMR, saving time, costs, and most importantly, lives in the process.
4 ISAM414-2 Positive KPC-2
5 KB068 Positive (adjuvant) NDM-1
6 LC544 Positive NDM-1, VIM-2, mphA
7 LC450 Positive None (except one wt colony)
8 LC346 Positive None
9 LC341 Positive KPC-2
10 LC520 Positive KPC-2
11 LC530 Positive (adjuvant) NDM-1
13 KB017A Positive None
16
LC178 Positive KPC-2
LC030 Negative
17
LC015 Positive (adjuvant) NDM-1, VIM-2, mphA
LC558 Positive (adjuvant) NDM-1, VIM-2, mphA
18
KB047 Negative
LC439 Positive KPC-2
19 LC041 Negative
21 LC418 Positive None (except two wt colonies)
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